American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$460M |
| 2 |
Broadcom
AVGO
|
+$298M |
| 3 |
Sysco
SYY
|
+$225M |
| 4 |
MRSH
Marsh
MRSH
|
+$200M |
| 5 |
Ascendis Pharma A/S
ASND
|
+$186M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$573M |
| 2 |
Visa
V
|
+$465M |
| 3 |
Apple
AAPL
|
+$461M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$363M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$358M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.8% |
| 2 | Financials | 13.6% |
| 3 | Consumer Discretionary | 12.52% |
| 4 | Industrials | 10.05% |
| 5 | Healthcare | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GOOS
2401
Canada Goose Holdings
GOOS
$850M
| $737K | ﹤0.01% |
56,876
+24,042
| +73% | +$320K |
|
|
DAWN
2402
DELISTED
Day One Biopharmaceuticals
DAWN
| $736K | ﹤0.01% |
78,925
+45,060
| +133% | +$376K |
|
2403
Ginkgo Bioworks
DNA
$488M
| $734K | ﹤0.01% |
88,295
+8,157
| +10% | +$87.8K |
|
2404
Citi Trends
CTRN
$621M
| $730K | ﹤0.01% |
17,566
+3,089
| +21% | +$122K |
|
2405
Latham Group
SWIM
$889M
| $729K | ﹤0.01% |
114,726
-38,405
| -25% | -$269K |
|
2406
OrthoPediatrics
KIDS
$653M
| $728K | ﹤0.01% |
40,967
+1,042
| +3% | +$18.2K |
|
2407
NewtekOne
NEWT
$378M
| $722K | ﹤0.01% |
63,620
-86
| -0.1% | -$938 |
|
|
ELME
2408
Elme Communities
ELME
$144M
| $720K | ﹤0.01% |
41,385
+612
| +2% | +$10.4K |
|
2409
Tandem Diabetes Care
TNDM
$1.61B
| $720K | ﹤0.01% |
32,760
+11
| +0% | +$199 |
|
2410
Hawthorn Bancshares
HWBK
$277M
| $719K | ﹤0.01% |
20,603
| – | – |
|
|
GTY
2411
Getty Realty Corp
GTY
$2.05B
| $718K | ﹤0.01% |
26,235
+5,843
| +29% | +$161K |
|
2412
National Beverage
FIZZ
$2.93B
| $713K | ﹤0.01% |
22,365
-5,843
| -21% | -$201K |
|
|
CTEV
2413
Claritev Corp
CTEV
$716M
| $707K | ﹤0.01% |
16,529
-4,175
| -20% | -$212K |
|
2414
Enliven Therapeutics
ELVN
$4.25B
| $705K | ﹤0.01% |
45,792
+34,283
| +298% | +$683K |
|
2415
Solventum
SOLV
$14.7B
| $703K | ﹤0.01% |
8,874
-65,535
| -88% | -$5.02M |
|
2416
Xperi
XPER
$320M
| $703K | ﹤0.01% |
119,961
+1,972
| +2% | +$12.4K |
|
2417
Array Technologies
ARRY
$796M
| $697K | ﹤0.01% |
75,562
-2,092
| -3% | -$17.9K |
|
2418
Warby Parker
WRBY
$3.2B
| $694K | ﹤0.01% |
31,829
-6,058
| -16% | -$132K |
|
2419
Consumer Portfolio Services
CPSS
$208M
| $692K | ﹤0.01% |
74,162
| – | – |
|
2420
Energy Recovery
ERII
$399M
| $692K | ﹤0.01% |
51,288
-11,504
| -18% | -$174K |
|
|
STKL
2421
DELISTED
SunOpta
STKL
| $688K | ﹤0.01% |
180,680
+2,785
| +2% | +$12.6K |
|
2422
Genesco
GCO
$394M
| $686K | ﹤0.01% |
27,704
-2,293
| -8% | -$65.8K |
|
|
TBRG
2423
DELISTED
TruBridge
TBRG
| $683K | ﹤0.01% |
30,966
+1,196
| +4% | +$25K |
|
2424
4D Molecular Therapeutics
FDMT
$609M
| $683K | ﹤0.01% |
91,084
+21,465
| +31% | +$218K |
|
2425
Vita Coco
COCO
$3.77B
| $677K | ﹤0.01% |
12,766
-634,491
| -98% | -$29.8M |
|
Similar funds
American Century Companies's Q4 2025 Portfolio in Review
As of Q4 2025, American Century Companies held 2,902 positions worth $199B, up 1.2% from $197B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
American Century Companies's Q4 2025 filing shows 123 new, 1,653 increased, 947 reduced and 91 closed positions. Its largest new stake was Amrize Ltd: 2,173,524 shares worth $118M. The largest sale was NVIDIA, an estimated $573M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- American Century Companies's largest Q4 2025 buy was Amrize Ltd: 2,173,524 shares worth $118M.
- American Century Companies added most to Amphenol in Q4 2025, an estimated $460M increase.
- American Century Companies's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $573M.
- American Century Companies fully exited Premier in Q4 2025, selling an estimated $91.5M.
- American Century Companies's ten largest holdings make up 27% of its $199B portfolio in Q4 2025.
- American Century Companies opened 123 new positions and closed 91 in Q4 2025.
- American Century Companies's portfolio value rose 1.2% quarter-over-quarter to $199B.
Based on American Century Companies's 13F filing for Q4 2025, filed 13 Feb 2026.